CUR@DOMUM (Curadomum) is a specialized Belgian healthcare services provider focused on decentralized clinical trials (DCT) and home-based patient support. The company bridges the gap between traditional clinical site visits and remote patient monitoring by providing professional nursing services and clinical coordination directly at the patient's residence. The firm is closely associated with the digital health sector in Belgium, with its leadership also tied to Remecare, a prominent remote patient monitoring platform. CUR@DOMUM facilitates complex clinical procedures in a home setting, such as blood draws, drug administration, and patient assessments, enabling pharmaceutical companies to improve trial recruitment, retention, and diversity through more patient-centric study designs.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Decentralized Clinical Trials (DCT) & Patient Support
SIZE & FINANCIALS
Employees:1-50
Revenue:Less than $1M
Founded:2009
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Patient Support Programs, Home Nursing, Clinical Trial Coordination
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Remecare (Digital platform integration for remote monitoring), Various Belgian clinical trial sites and CROs
COMPETITION
Position:Niche Player
Competitors:Illingworth Research Group, PCM Trials, MRN (Medical Research Network), Symaps
LEADERSHIP
Key Executives:
Katrien Brutsaert - Managing Director & Clinical Research Professional
Koen Goyens - Director
Scientific Founders:Katrien Brutsaert
Board Members:Katrien Brutsaert, Koen Goyens
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CUR@DOMUM. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.